Another armed CD4+ T cell ready to battle hepatocellular carcinoma
Roniel Cabrera, Gyongyi Szabo – 8 March 2013
Conversion from twice daily tacrolimus to once daily tacrolimus in long‐term stable liver transplant recipients: A single‐center experience with 394 patients
Jérôme Dumortier, Olivier Guillaud, Olivier Boillot – 8 March 2013 – After organ transplantation, strategies for simplifying the therapeutic regimen may improve adherence and prevent acute organ rejection and/or late graft loss. The aim of the present study was to evaluate the safety and efficacy of conversion from a tacrolimus (TAC) twice daily (bid) formulation to a once daily (qd) formulation in a large cohort of adult liver transplantation (LT) patients.
Hepatitis C virus 1b viral factors (core, NS3, and NS5A) and increased risk of hepatocellular carcinoma
Suresh D. Sharma – 7 March 2013
Concordance between sustained virologic response week 12 (SVR12) and SVR24 in genotype 1 hepatitis C virus patients receiving interferon‐free treatment in the SOUND‐C2 study
Stefan Zeuzem, Federico J. Mensa – 7 March 2013
Therapy for lysosomal acid lipase deficiency: Replacing a missing link
Gregory Grabowski – 7 March 2013
Therapy for lysosomal acid lipase deficiency: Replacing a missing link
Gregory Grabowski – 7 March 2013
Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study
George F. Mells, Greta Pells, Julia L. Newton, Andrew J. Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James M. Neuberger, Darren B. Day, Samantha J. Ducker, Richard N. Sandford, Graeme J. Alexander, David E.J. Jones, UK‐PBC Consortium – 7 March 2013 – Primary biliary cirrhosis (PBC) has a complex clinical phenotype, with debate about the extent and specificity of frequently described systemic symptoms such as fatigue.
Hepatopulmonary syndrome and liver transplantation: Who, when, and where?
Rajasekhar Tanikella, Michael B. Fallon – 7 March 2013
Hepatopulmonary syndrome and liver transplantation: Who, when, and where?
Rajasekhar Tanikella, Michael B. Fallon – 7 March 2013
The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus
Piero Amodio, Chantal Bemeur, Roger Butterworth, Juan Cordoba, Akinobu Kato, Sara Montagnese, Misael Uribe, Hendrik Vilstrup, Marsha Y. Morgan – 7 March 2013 – Nitrogen metabolism plays a major role in the development of hepatic encephalopathy (HE) in patients with cirrhosis. Modulation of this relationship is key to the management of HE, but is not the only nutritional issue that needs to be addressed. The assessment of nutritional status in patients with cirrhosis is problematic.